Aptinyx Inc. is a clinical-stage biopharmaceutical company discovering and developing transformative therapies for challenging disorders of the brain and nervous system. Our proprietary NMDA receptor modulator discovery platform enables a differentiated approach to developing novel therapeutic solutions across numerous CNS disorders. We are currently evaluating compounds from our platform in late-stage clinical development across chronic pain, post-traumatic stress disorder, and cognitive impairment.